Post Profile

Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer

A phase III trial of sunitinib has met its primary endpoint of disease-free survival for adjuvant treatment of high-risk renal cell carcinoma after nephrectomy, researchers report.
read more


Related Posts

Phase III C-08 Study Of Avastin In Early-stage Colon Cancer Does Not Meet Primary Endpoint

Health : Medical News Today

Roche announced the results of the first phase III trial evaluating the use of Avastin (bevacizumab) plus chemotherapy (FOLFOX) for the treatment of colon cancer immediately following surgery (adjuvant therapy) compared to chemother...

In Patients With Metastatic Renal Cell Carcinoma Scientists Investigate Potential Markers For A Response To Sunitinib

Health : Medical News Today

Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study ...

Renal Cell Carcinoma Phase III Data

Health : Medical News Today

New trial results on pazopanib and temsirolimus have important implications for patients New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Co...

Phase III Trial Of L-BLP25 In Patients With Non-Small Cell Lung Cancer (START) - Primary Endpoint Of Significantly Improving Overall Survival Not Met

Health : Medical News Today

Confirmed: Primary endpoint of significantly improving overall survival not met Merck Serono, a division of Merck, Darmstadt, Germany, today announced detailed results from the randomized Phase III START trial of its investigational...

Sunitinib Benefits Patients with Renal Cell Carcinoma

Health : Newswise Medical News

Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals.


Copyright © 2016 Regator, LLC